The ABPI and Health Innovation Manchester were shortlisted for ‘Best Pharmaceutical Partnership’ in the HSJ partnership awards last night. Partnership working with the NHS is the way forward, says ABPI Chief Executive Mike Thompson.
Earlier this week the British Medical Journal (BMJ) published and publicised a story which we believe inaccurately depicts the work of the pharmaceutical industry in the UK. Our chief executive Mike Thompson has written a letter to the BMJ in response.
Ahead of Wednesday's Spring Budget, ABPI Chief Executive, Mike Thompson, has outlined three key asks that the pharmaceutical industry has put to the Treasury.
The Life Sciences Industrial Strategy was launched, and received, with much enthusiasm this week at the Institute of Translational Medicine. It was a fitting venue: a world-class clinical research facility in Birmingham that helps progress scientific research into the latest treatments for NHS...
The ABPI have welcomed the announcement of the appointment of Kristen McLeod as new Director for the Office of Life Sciences (OLS), effective 13 November 2017.
Following today/yesterday’s announcement by Science Minister, Jo Johnson, of the non-executive Board members of UK Research and Innovation (UKRI), the ABPI’s Chief Executive Mike Thompson has moved to welcome the new appointees.